🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Advanced Gynecologic Tumors

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy NCT04957511n/a1 site📍 Orlando Viome BOLSTER: Learning New Skills to Thrive NCT06936878NA2 sites📍 Boston📍 Houston Dana-Farber Cancer Institute · Tests: BOLSTER Program A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital) NCT05098171EARLY Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Signal Switch Receptor Modified TIL Advanced Pelvic Surgical Oncology Database - Prospective Observational Study NCT05696002n/a1 site📍 Glasgow Glasgow Royal Infirmary First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors NCT05768139Phase 1, Phase 265 sites📍 Los Angeles📍 San Francisco📍 Aurora Eli Lilly and Company · Tests: STX-478, Fulvestrant, Ribociclib, Palbociclib, Letrozole A Study of GC203 TIL in Advanced Malignant Solid Tumors NCT06375187Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Engineering Tumor Infiltrating Lymphocytes Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies NCT07434284EARLY Phase 11 site📍 Shanghai Obstetrics & Gynecology Hospital of Fudan University · Tests: cCTL treatment Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors NCT06993844Phase 1, Phase 215 sites📍 Newport Beach📍 San Francisco📍 New Haven Ensem Therapeutics · Tests: ETX-636 dose escalation, ETX-636 dose escalation in combination with fulvestrant, ETX-636 dose expansion in combination… Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs). NCT07406789Phase 21 site📍 Madrid TNC Nutrición Terapéutica S.L. · Tests: Personalised dietary intervention., General recommendations Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies NCT06626269NA2 sites📍 Besançon📍 Dijon Centre Hospitalier Universitaire de Besancon · Tests: Blood sample, Tumor tissue A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer NCT06215950Phase 11 site📍 Wuhu Chongqing Precision Biotech Co., Ltd · Tests: CD70 CAR-T cells, CD70 CAR-T cells Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART) NCT06306170n/a1 site📍 Milan IRCCS San Raffaele · Tests: Image Guided Radiotherapy Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors NCT07444814Phase 112 sites📍 Little Rock📍 Los Angeles📍 Peoria Whitehawk Therapeutics, Inc. · Tests: HWK-007 A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients NCT06522828Phase 21 site📍 Chongqing Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Tests: SSGJ-707, carboplatin, paclitaxel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy